Search results
Results from the WOW.Com Content Network
The test was once part of the World Health Organization (WHO) algorithm for diagnosis of dengue fever, [3] however it is no longer used in the latest WHO guidance. [4] Studies have shown that the tourniquet test has low predictive value for dengue fever and should be used in conjunction with other tests for a reliable diagnosis. [5] [6] [7] [8]
The Hess test or Rumpel-Leede test is a medical test used to assess capillary fragility. [1] It is also called the Tourniquet test . To perform the test, pressure is applied to the forearm with a blood pressure cuff inflated to between systolic and diastolic blood pressure for 10 minutes.
Treatment of acute dengue is supportive, using either oral or intravenous rehydration for mild or moderate disease, and intravenous fluids and blood transfusion for more severe cases. The incidence of dengue fever has increased dramatically since the 1960s, with around 50–100 million people infected yearly. Early descriptions of the condition ...
The symptoms experienced by those infected with dengue can vary widely: up to 80% of dengue cases are asymptomatic, and while some infections may trigger only flu-like symptoms, more serious cases ...
Dengue fever is a mosquito-borne illness that is typically prevalent in tropical and subtropical areas, according to the Mayo Clinic. The illness can cause high fever and flu-like symptoms .
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic ; if symptoms appear they typically begin 3 to 14 days after infection.
Article says: "The test remains an essential part of the assessment of a patient who may have dengue haemorrhagic fever." Since this is in the context of a statement that a major insurance company has determined that this test is obsolete or unreliable and replaced it by more advanced procedures, we may want to clarify by whom exactly this test is (still) considered essential.
Infants, pregnant women, adults 65 and over and those with certain medical conditions face an increased risk of severe dengue. There are no antiviral medications approved to treat dengue.